Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
monoclonal antibody
|
| gptkbp:clinicalTrials |
Phase 1
|
| gptkbp:developedBy |
gptkb:Xencor
|
| https://www.w3.org/2000/01/rdf-schema#label |
XmAb®18087
|
| gptkbp:mandates |
B-cell malignancies
|
| gptkbp:origin |
humanized
|
| gptkbp:related_to |
high affinity for CD19
|
| gptkbp:route |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:targets |
CD19
|
| gptkbp:triggerType |
antibody-dependent cellular cytotoxicity
|
| gptkbp:usedFor |
treatment of cancer
|